Stocks · News reference

Cantor Fitzgerald Maintains Overweight on Eli Lilly, Raises Price Target to $1440

Oct 8, 2026, 10:43 AMBenzinga Newsdesk

Cantor Fitzgerald analyst Carter Gould maintains Eli Lilly (NYSE:LLY) with a Overweight and raises the price target from $1410 to $1440.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaOct 8, 2026, 10:35 AMMohd Haider
Pharma Lobby Sues Trump Administration Over Medicare Drug Pricing Rule, Calls It ‘Unlawful Overreach’ — ‘The Results Are Preordained’
PhRMA sued the Trump administration over its Medicare drug pricing rule, arguing CMS exceeded its authority under federal law.
LLY NVO PFE
BenzingaOct 8, 2026, 7:50 AMAvi Kapoor
Dow Falls Over 300 Points As Treasury Yields Surge: Investor Sentiment Weakens, Fear & Greed Index Remains In ‘Neutral’ Zone
Market sentiment slipped but stayed neutral as U.S. stocks fell amid rising Treasury yields; mortgage applications declined for a fifth week.
HELE LLY PEP TLRY
BenzingaOct 7, 2026, 4:53 PMPiero Cingari
Stock Market Today: S&P 500, Russell 2000 Fall as 30-Year Yield Hits 5.7%
Stocks fell and small caps slumped Wednesday as the 30-year Treasury yield hit 5.7%, a 24-year high, with Fed minutes and bond auctions ahead.
CAT CGNX DIA GDX GLD